Latest Marburg virus disease Stories
DALLAS, April 15, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Marburg Hemorrhagic Fever - Pipeline Review, H1 2015" therapeutic market research report of 48 pages
- A single administration of Profectus VesiculoVax(TM)-vectored vaccine rapidly provides complete protection of non-human primates from sickness and death when challenged with lethal dose of Makona
This year's Ebola virus outbreak may have originated from contact between humans and infected bats, according to new research published in the journal EMBO Molecular Medicine on Tuesday.
A large team of American researchers has successfully completed the first step toward developing a vaccine for the Ebola virus.
As diseases like Ebola demonstrate how a virus can easily spread across communities, borders and oceans,
- Funding to support GMP manufacture of VesiculoVax(TM)-vectored vaccines for Zaire-Ebola virus, Sudan-Ebola virus, and Angola-Marburg virus that will be blended into a single formulation; rapid
A new study is helping to rewrite Ebola’s family history. The research shows that filoviruses — a family to which Ebola and its similarly lethal relative, Marburg, belong — are at least 16-23 million years old.
Ebola detection kits for humans and animals are now possible using ADI antibody or antigen ELISA kits with results in less than 2 hours.
-- Funding to Support Profectus and Galveston National Laboratory Investigators in the Development of a Trivalent rVSV-Vectored Vaccine to Rapidly Confer Protection Against Ebola and Marburg Viruses
-- Studies will accelerate IND-enabling development of VesiculoVax(TM) Ebola vaccine -- BALTIMORE, Oct. 22, 2014 /PRNewswire/ -- Profectus BioSciences, Inc.
- a slit in a tire to drain away surface water and improve traction.